Procter & Gamble (NYSE: PG) wants to calm the nerves of jittery Wall Street. According to this item, the Kimberly-Clark (NYSE: KMB) warning has spooked investors worried about inflation (I'm one of them). So, P&G wanted to let everyone know that things will be all right at the maker of Ivory soap and Pringles potato chips (or is that crisps?).

P&G is confident that it can deliver top-line growth of between 8% and 10% when it next reports. Also, management believes that earnings per share will still be somewhere between $0.76 and $0.78. You know it's a bad market when an announcement indicating that the status quo will merely be maintained as opposed to being exceeded is enough to keep a stock slightly in the green by a few pennies, as opposed to down nearly 5% (which is how the stocks of P&G and Kimberly-Clark are trading, respectively, as of this writing).

Of course, the fact that P&G came out and supported its guidance doesn't mean that inflation shouldn't be feared. We're still in bad shape in this regard, the bears haven't gone away, and I don't think either P&G or Kimberly-Clark are trading buys. I like both for the longer-term, and in terms of Kimberly-Clark, the yield is attractive. However, in terms of buy-and-hold-and-forget, you can't beat the safe reliability of P&G, whose product portfolio is one of the best out there in the consumer sector. I would imagine that P&G's brand equity is helping it navigate this vicious commodity storm, but don't think it can't weaken in coming quarters.

Disclosure: I don't own any stock mentioned; positions can change at any time.

Well-known maker of peanut-butter and jelly products J.M. Smucker (NYSE: SJM) reported earnings for Q4 and the full fiscal year on Thursday. The market didn't like the report in the least. The stock closed down well over 8% at the end of yesterday's session.

Here's what happened. For the fourth quarter, net sales increased 20%, but that was little consolation to the bottom line, which dropped 11%, as earnings per diluted share came in at $0.67 versus $0.75 in the year-ago period. The top line also was the beneficiary of some inorganic growth based on acquisitions. If you adjust for certain items, bringing the earnings up to $0.73 per diluted share, the decrease in the bottom line improves to 3%, but a decline in this case is still a decline. Plus, earnings expectations were not met. The company came in five pennies shy of Wall Street's wishes, according to estimates posted at earnings.com.

For the fiscal year, J.M Smucker's top line increased 18%, also due in part to acquisitions. On both a reported and an adjusted basis, earnings per diluted share jumped 9% to $3.00. Margins really suffered during the quarter and the year. Input costs are inflating, and they're becoming difficult to manage.

I love coupons; who doesn't? They are, arguably, one of the most important marketing tools used by companies such as Procter & Gamble (NYSE: PG), Colgate-Palmolive (NYSE: CL), and General Mills (NYSE: GIS). I also love coupon distribution on the web, so I'm hoping a new technology reported on by BusinessWeek really takes off.

A company called Coupons, Inc. has developed a system dubbed Brandcaster. It essentially follows Google's (NASDAQ: GOOG) model of monetization. Depending on where you are on the web and what you are looking at, the Brandcaster will determine if a coupon may be applicable to you. It will then try to get you to access the coupon and print it up. Web sites who use the application will be given a cut of revenues generated from successful coupon printings. So, speaking hypothetically, if I'm on a site that's dedicated to video games, maybe this Brandcaster thing will someday tell me that I can print up a coupon allowing me to get $5 off a new software title.

If this is promoted properly, and if the value to consumer companies can be adequately communicated, then I think Coupons, Inc. has a hit on its hands. Like I say, people love coupons, and I think they are more likely to act on printing out a coupon then they are to, say, buy a product immediately online through a banner ad. I see this kind of advertising as being more effective over the long-term than other kinds of ads.

"Beauty is as beauty does, the saying goes, and Avon Products Inc. (NYSE: AVP) has delivered a beautiful earnings report," says Jack Adamo in his industry-leading Insiders Plus. Here's his latest.

"Despite a 14% increase in advertising (or perhaps, because of it) the company delivered EPS up 26%. In North America, the only underperforming region, revenues continued their slow downward slide. But active representatives increased for the first time in ages, which may brighten the future on the company's home turf.

"International sales continued to soar. Latin America was 19% higher in local currencies, and 32% higher after translation into the American Peso, also known as the U.S. Dollar. In Central & Eastern Europe, first-quarter revenue rose 17% (6% in local currency). Revenue in China grew 29% (19% local). Only Japan dragged things down a bit with its 2% gain.

Colgate-Palmolive (NYSE: CL) reported Q1 results on Wednesday. By now, you know the drill when it comes to consumer-products companies -- weak-dollar-helped-and-commodity-costs-did-not-help. I gotta say, though, that Colgate-Palmolive showed that vigilance in terms of costs can have a positive impact, and that a business does not have to be defined by inflation.

Net sales exploded to the upside by more than 15% (again, currency effects). Net income likewise charged higher, rising 17% to 90 cents per share on an adjusted basis. I know -- superlatives such as "exploded" and "charged higher" might seem a bit hyper here, but it's always cool when a consumer-products company hits those double-digit increases. Colgate-Palmolive, like Clorox (NYSE: CLX) and Procter & Gamble (NYSE: PG), leverages its stable of brands to drive growth in cash flows (Procter & Gamble, by the way, also recently reported quarterly results). This worked like a charm, since cash flow from operations during the past three-month period increased 17%. Way to go, management. Margins, however, were pressured, as can be expected, and they will continue to be pressured in the near future.

The earnings release mentioned the flagship Colgate toothpaste product -- I am a user of the brand, and in fact, I bought a new variety earlier this week. I've said it before and I'll say it again -- the supermarket is full of investing ideas, and Colgate-Palmolive is one of them. The company had a great quarter, it beat expectations according to Briefing.com -- albeit by the usual suspect, namely the "proverbial penny" -- and it seems solid enough. A potential core holding, Colgate-Palmolive should do well over the coming year. Yesterday's 6.7% drop in the price of the shares could have been seen as a buying opportunity for patient, long-term investors, but I'll concede that the stock could languish for a little while.

Disclosure: I don't own shares in any of the companies mentioned; positions can change at any time.

Kimberly-Clark (NYSE: KMB) reported for the first quarter today. Net sales increased almost 10% to $4.8 billion. Adjusted earnings per share increased 5% to $1.08. That's a rather small jump, granted, but you know something, it was enough to keep the stock in the green (at the time of this writing, at least) instead of in the red on a day when the major market averages -- and just about all of the stocks in my personal portfolios -- are bathing in the evil crimson color of doom. And according to Briefing.com, Kimberly-Clark played the beat-the-expectations game and won by the proverbial penny! Shareholders should be pleased.

A non-pleasing item to be found in the release centers on cash from operations -- it decreased by about $100 million to $426 million due to changes in working capital. That doesn't concern me so much right now, though, since Kimberly-Clark will probably do well over the coming years in terms of cash generation. The company, by the way, has been repurchasing stock, so management seems pleased with the shares as a potential investment idea.

Kimberly-Clark, which is a consumer-products business in the league of entities such as Procter & Gamble (NYSE: PG), Energizer (NYSE: ENR), Colgate-Palmolive (NYSE: CL), and Unilever (NYSE: UL), could be a value right now based on its P/E ratio and dividend yield. Out of the stocks mentioned here, I like P&G the best, but I do respect Kimberly-Clark -- in fact, it was mentioned recently in an article by Steven Halpern that centered on an analyst's picks for quality and yield.

Disclosure: I don't own shares in any of the companies mentioned; positions can change at any time.

Readers of this space know that the investment bias is toward large-cap companies with demonstrated business models and who have a competitive advantage in established markets, preferably with a favorable global trend as a support. And with the above in mind, Coca-Cola is worth an evaluation.

This is not your parents' The Coca-Cola Company (NYSE: KO) company. This is the drink-diversified KO. Coca-Cola has adeptly positioned itself in the health (Vitamin Water) and sports drink (Powerade) segments, while continuing to effectively publicize one of the most iconic brands in the world, its namesake cola drink.

Other positives: KO has dominant or large-lead market share positions in key developed nations, an impressive emerging market presence, a superior balance sheet, and marketing skills that many companies can only dream about. The Reuters FY 2008/FY 2009 EPS consensus estimates for KO are $3.03 to $3.32.

With the markets still in a choppy/consolidation mode (or perhaps worse), it's best to consider including a few defensive stocks in your portfolio, and with the aforementioned in mind Colgate-Palmolive is worth an evaluation.

Colgate-Palmolive Company (NYSE: CL)'s restructuring is working, and its 2008/2009 results will continue to show it. In late 2004 CL initiated a 4-year cost reduction program including a 10% workforce reduction, new product roll-outs, an emphasis on larger-growth markets, and the more-savvy deployment of marketing resources.

The results to-date? The CL train is moving forward, with analysts generally seeing near-double-digit annual revenue growth through at least 2009, and probably longer. An eye-opening stat -- Colgate is an enhanced, global consumer products defensive play: 65% of CL's revenue stems from personal, oral, and home care sales outside North America.

With the markets still in a choppy/consolidation mode (or perhaps worse), it's best to consider including a few defensive stocks in your portfolio, and with the aforementioned in mind Procter & Gamble is worth a review.

If General Electric Company (NYSE: GE) is 'the mutual fund in one company,' then The Procter & Gamble Company (NYSE: PG) is the 'consumer products aisle' in one company. Pick a brand, any brand. PG has about 300, including names you know well: Crest toothpaste, Folgers coffee, Bounty paper towels, Tide detergent, Gillette shavers - - PG's core product line contains brands that are entrenched in U.S. culture... and entrenched in U.S. consumer buying patterns.

Procter & Gamble says its mission is "to provide superior quality and value to the world's consumers," and both revenue and consumer satisfaction surveys suggest it is 'on message,' to borrow a political campaign strategy phrase.

A choppy, indecisive market requires a defensive play or two as a safety net, and a defensive stock worthy of consideration is Newell Rubbermaid (NYSE: NWL).

Newell Rubbermaid doesn't strictly fit the definition of a defensive stock, but its signature product, combined with its overall diversity in the consumer product space, make the stock a worthy consideration.

Newell Rubbermaid's signature product is the food storage container. At first glance, one could argue that U.S. shoppers will buy fewer of these containers as the U.S. economy slows, as it is, strictly speaking, a discretionary purchase. Still, we know from previous belt-tightening periods Americans tend to cut back on dining out. Undoubtedly that means more home prepared meals, and leftovers, which need containers -- a positive trend for Rubbermaid.

If recent market turbulence has dented your investment confidence, or if you're concerned about a continued U.S. economic slowdown heading into 2008, consider purchasing Clorox's shares.

Look for The Clorox Company (NYSE: CLX) to keep rolling along. Or, put another way, when will bleach use go out-of-style?

The world's best-known bleach brand has further impressed investors with its lesser-known, but profitable operations: Specialty Group [cat liter, charcoal products, dressings and sauces, Glad brand bags/containers], along with its International Group, which sell products in Latin America and Asia that are similar to those in North America.

What's more, bleach remains a key revenue driver, but in fiscal 2007 Glad trash bags accounted for 14% of revenue, Clorox about 12%.

The risks? Analysts have their eye on rising commodity costs, but CLX's cost cutting programs and pricing power should more than compensate for that concern, in the immediate years ahead. That fact, combined with the company's demonstrated proficiency in marketing, make CLX a low-risk investment. CLX's p/e of 19 is not low, but it's reasonable given its growth prospects and the amount safety the company affords.

The Reuters F2008/F2009 EPS consensus estimates for CLX are $3.40 to $3.99.

The First Call mean rating for CLX is: Hold. [15 firms.] Mean 2007 target: $67.40. [high: $78, low: $58.]

Stock Analysis: Clorox is a low-risk stock. Consider buying Clorox's shares if your portfolio needs a consumer defensive stock. Investors with an investment horizon longer than 1 year should be rewarded from CLX's shares. Sell / Stop Loss if you were to purchase shares of this company: $44.

We all know that diversification is one of the key fundamentals in long-term financial planning. 3M Company (NYSE: MMM), a nearly century-old technology company that produces everything from surgical supplies and flat screen TVs to asphalt shingles and that old reliable Scotch Tape, shows how to put that principle into practice. Not only do the company's products cover a wide cross-section of the technology marketplace, but its increasing reach into foreign markets allows the company to offset slow sales in the U.S. with international activity, and also to take advantage of a weak dollar by encouraging foreign investment.

Recent expansions of 3M's holdings in Eastern Europe, South America and Asia allow the company to continue to spread the risk of local instability over a worldwide organization, as well as provide new markets for products that have long been profitable in the U.S.

The third quarter earnings last week did show a reduction in the company's annual revenue forecast, causing the stock price to fall from this year's highest price of $95.82 (only two weeks ago) to its current price in the mid $80s. However, those same 3rd quarter returns also showed a solid increase in net income for the quarter (7.4%), and the company raised its annual earnings forecast to levels above analysts' expectations. What this means for a smart investor is that you can pick up a stock Goldman Sachs is valuing at $97 for almost $10 less -- and you should see a return in fairly short time.

As discussed, with the markets in a choppy/consolidation mode (or perhaps worse), the consumer product sector has appeal as a defensive strategy, and Colgate-Palmolive (NYSE: CL) is worth a review.

Colgate's restructuring is working, and Wall Street expects 2007/2008 results to show it. In late 2004, CL initiated a 4-year cost reduction program including a +10% workforce reduction, new product roll-outs, an emphasis on larger-growth markets, and the more-adept deployment of marketing resources.

The results to-date? The CL train is on-time, with analysts generally seeing low-double-digit annual revenue growth through at least 2008, and probably longer. An eye-opening stat -- Colgate is an enhanced, consumer products defensive play: 65% of CL's revenue stems from personal, oral and home care sales outside North America. Hence, even if U.S. consumer goods sales slump badly (which is not likely) CL can look for international consumer product operations to support results. The Reuters F2007/F2008 revenue consensus estimates for CL are $13.5 billion / $14.4 billion. Colgate's shares Tuesday afternoon traded 23 cents higher to $73.18

The beauty of the Internet is that news and events can circulate globally in a matter of minutes. The bad news about the Internet is news and events can circulate globally in a matter of minutes. Just ask Crocs (NASDAQ: CROX) about the latter statement. The stock has suffered over an Associated Press article that is frankly -- a crock.

The gist of the AP article was that Crocs harmed a few children on escalators. As a father of five and a grandfather of two, I get kids. I also get kids' accidents. I have spent my fair share of time in emergency rooms with sports-related and household type injuries with my children! The AP article strongly suggested that the Crocs shoes worn by little children was the cause of their unfortunate accidents by catching their toes or feet in the teeth of the escalator. Some have required medical attention including suturing wounds or a broken foot.

To outright blame the Crocs shoes for these accidents is both unfair and pretty easy to do. It certainly has caught the attention of the concerned parents of the world and will cause some to rethink a possible purchase. Everyday life carries risks and of course, as parents, we strive to minimize those risks. If not Crocs shoes, then whose shoes are absolutely, guaranteed safe and escalator proof? None.

Procter & Gamble Co. (NYSE: PG) today reported strong fiscal fourth quarter profits, improving margins and raised a stock buyback. Shares are rising in pre-market action even though the world's largest consumer products company also gave disappointing earnings guidance.

Profit rose 19% to $2.3 billion, or 67 cents per share, from $1.9 billion, or 55 cents, helped by gains in Blades & Razors, Fabric & Home Care and Beauty and Health Care. Revenue rose 8% to $19.3 billion. Results beat analysts' forecasts which called for profit of 66 cents on revenue of $19.11 billion.

Procter & Gamble also announced plans to repurchase between $24 billion and $30 billion worth of company shares over the next three years, at about $8 billion to $10 billion a year. This represents an increase over the $5.6 billion acquired in the last fiscal year.

"They're not shooting the lights out, but they're doing the right things to increase sales,'' Procter & Gamble shareholder John Kornitzer, chief investment officer at Kornitzer Capital Management, told Bloomberg News.

Earnings will be $3.44 to $3.47 for the current fiscal year, which is below the $3.47 analysts had expected. Sales are expected to rise between 5 to 7%. Analysts were expecting a rise of 5.8%, according to Thomson Financial.

The 88-cent to 90-cent profit forecast for the quarter, lags the 91 cents Wall Street had expected. Procter & Gamble sees sales rising 6 to 8 percent while analysts saw a gain of 6%.